Landmark Skybox

Breeze-Courier | Taylorville, IL
The Weather Network
Advanced Search
search sponsored by


LOGIN | SUBSCRIBE




KMRM

home : news : national news free February 28, 2020

12/12/2019 1:10:00 PM
Pelosi drug bill up for vote reflects a Trump idea

WASHINGTON (AP) — As a White House candidate, Donald Trump said he could save Medicare billions of dollars by negotiating prescription drug prices.

Legislation expected to pass the Democratic-controlled House on Thursday would deliver that and much more.

But Trump’s not on board, the White House is threatening a veto and Republicans who run the Senate say they will ignore the bill by House Speaker Nancy Pelosi, D-Calif., because they say the government shouldn’t negotiate drug prices.

That’s not stopping Democrats from savoring the moment. They contend Trump’s disapproval shows a lack of conviction behind some of his populist pitches.

They’re also betting that Pelosi’s plan will prove popular with 2020 voters, helping elect Democrats who will eventually be in a position to pass something like it.

The bill would cap drug copays and deductibles at $2,000 a year for Medicare recipients. It would use about $360 billion of its projected 10-year savings from lower drug costs to create Medicare coverage for dental care, hearing, and vision, filling major gaps for seniors.

“We were sent to Washington with a mandate to bring down the cost of prescription drugs and to deliver for the American people — this will untie the hands of the federal government to negotiate prices,” said Rep. Haley Stevens, D-Mich., as debate got underway. She is a member of the freshman class that enabled Democrats to regain control of the House in 2018; her district went for Trump in 2016.

White House officials say Pelosi’s bill is unworkable and that Trump wants something that can pass now. Near unanimous opposition from congressional Republicans means it would never clear the Senate.

Republican lawmakers predict Pelosi’s bill would stifle innovation and they urged House Democrats to seek a bipartisan compromise.

“Drugs that save lives will not be around,” said Rep. Greg Walden, R-Ore. “Innovation goes on the rocks; lives will be lost.”

A major concern about the legislation is that it will result in fewer drugs coming to market. But there’s debate about the extent. The nonpartisan Congressional Budget Office estimates about 3% to 10% fewer new drugs, while the White House Council of Economic Advisers says it could be much higher, up to one-third of new medications.

Rep. Bobby Scott, D-Va., who helped write the Pelosi bill, said Republicans predicting the drug pipeline will dry up are using scare tactics.

“Any drug that’s out there, we’re going to have access to,” he said. “The U.S. would still be the biggest market.”

The pharmaceutical industry is strongly opposed to the bill. Among the groups backing it is AARP.

High prescription drug prices consistently register in polls as the public’s top health care concern. But it’s unclear in a capital divided over Trump’s impeachment that any major legislation will pass before next year’s elections.

There’s a bipartisan Senate bill that would also cap seniors’ out-of-pocket costs, at $3,100 a year, and require drugmakers to pay Medicare rebates if companies raise prices above inflation. The plan has Trump’s support but Senate Majority Leader Mitch McConnell, R-Ky., hasn’t said if or when he’ll bring it to the floor.

Inflation rebates are included in Pelosi’s bill as well, so there is considerable overlap between the two major pieces of legislation before lawmakers. But Pelosi’s measure goes further with several unique features, including:

— Medicare would be authorized to negotiate prices for costly medications, using a formula based on lower prices paid in other economically advanced countries.

— Drugmakers who refuse to negotiate would be hit with steep sales taxes for the medication at issue. Republicans say proposed taxes as high as 95% are unconstitutional. The budget office projects that most pharmaceutical companies would opt to accept lower prices from Medicare.

— Private health insurance plans would be able to receive Medicare’s discounted prices.





Article Comment Submission Form
Please feel free to submit your comments.

If you are looking for the SPEAK OUT submission form, you can find it by clicking here: Speak Out Form


Article comments are not posted immediately to the Web site. Each submission must be approved by the Web site editor, who may edit content for appropriateness. There may be a delay of 24-48 hours for any submission while the web site editor reviews and approves it.

NOTE: All information on this form is required. Your telephone number and email address will not be displayed or shared.
Submit an Article Comment
First Name:
Required
Last Name:
Required
Telephone:
Required
Email:
Required
Comment:
Required
Passcode:
Required
Anti-SPAM Passcode Click here to see a new mix of characters.
This is an anti-SPAM device. It is not case sensitive.
   










Trinity Dodge Fixed
Dr Paul The Dentist
NewsWebPagesOpinionPeopleObituariesAg & BusinessSportsContact UsLife
Subscriptions | Username & Password Reminder | Change Password | Life

Breeze-Courier & Printing | 212 S Main St. Taylorville, IL 62568 | (217) 824-2233 |
website@breezecourier.com

© Copyright 2014 Breeze-Courier & Printing. All Rights Reserved.
Original content may not be reprinted or distributed without the written permission of Breeze-Courier & Printing.

Software © 1998-2020 1up! Software, All Rights Reserved